Skip to main content
SpringerLink
Log in

Thrombogenität verschiedener Krankheitsbilder

  • Chapter
Prävention von Thrombosen und Embolien in der Inneren Medizin

  • 533 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Teil II (Kapitel 6–10)

  • Bachleitner-Hofmann T, Grumbeck E, Gisslinger H (2003) Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients. Thromb Res 112: 229–232

    Article  PubMed  CAS  Google Scholar 

  • Bargen JA, Baker NW (1936) Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58: 17–31

    Google Scholar 

  • Barthels M, von Depka, M (2003) Das Gerinnungskompendium. Thieme, Stuttgart

    Google Scholar 

  • Bauduer F, Blanc A, Cordon B (2003) Deep vein thrombosis and acute cytomegalovirus infection: case report and review of the literature. Blood Coagul Fibrinolysis 14: 489–491

    Article  PubMed  Google Scholar 

  • Bermejo E, Alberto MF, Meschengieser SS, Lazzari MA (2004): Assessment of platelet activation in myeloproliferative disorders with complementary techniques. Blood Coagul Fibrinolysis 15: 235–240

    PubMed  CAS  Google Scholar 

  • Bernard GR (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709

    Article  PubMed  CAS  Google Scholar 

  • Braat EA et al. (1999): Fibrinolytic properties of activated FXII. Eur J Biochem 263: 904–911

    Article  PubMed  CAS  Google Scholar 

  • Brandt JT (2002) Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med 126: 1376–1381

    PubMed  CAS  Google Scholar 

  • British Society for Haematology (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109: 704–715

    Google Scholar 

  • Bura A, Cailleux N, Bienvenu B et al. (2004) Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2: 441–444

    Article  PubMed  CAS  Google Scholar 

  • Casserly LF, Dember LM (2003) Thrombosis in end-stage renal failure. Seminars in Dialysis 16: 245–256

    Article  PubMed  Google Scholar 

  • Cattaneo M, Vecchi M, Zighetti ML et al. (1998) High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 80: 542–545

    PubMed  CAS  Google Scholar 

  • Chandler WL, Rodgers GM, Sprouse JT, Thompson AR (2002) Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med 126: 1405–1414

    PubMed  CAS  Google Scholar 

  • Dahlbäck B (2004) APC resistance: what have we learned since 1993? J Lab Med 28: 21–27

    Google Scholar 

  • Emmerich J (2002) Infection and venous thrombosis. Pathophysiol Haemost Thromb 21: 346–348

    Google Scholar 

  • Encke A et al. (2003) Leitlinie zur stationären und ambulanten Thromboembolieprophylaxe in der perioperativen Medizin. Anästhesie und Intensivmedizin 44: 3–11

    Google Scholar 

  • Erbe M, Rickerts V, Bauersachs RM, Lindhoff-Last E (2003) Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Haemost 9: 325–331

    Article  CAS  Google Scholar 

  • Esmon CT (2003) The Protein C Pathway. Chest 124: 26S–32S

    Article  PubMed  CAS  Google Scholar 

  • Fäh F, Zimmerli W, Jordi M, Schoenenberger RA (2002) Septic deep venous thrombosis in intravenous drug users. Swiss Med Weekly 132: 386–392

    Google Scholar 

  • Fultz SL, McGinnis KA, Skanderson M, Ragni MV, Justice AC (2004) Association of venous thromboembolism with human immunodificiency virus and mortality in veterans. Am J Med 116: 420–423

    Article  PubMed  Google Scholar 

  • Geerts WH, Heit JA, Clagett GP et al. (2001) Prevention of venous thromboembolism. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001; 119: 132S–175S

    Article  PubMed  CAS  Google Scholar 

  • Hayes T (2002) Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 126: 1387–1390

    PubMed  Google Scholar 

  • Hemmer CF, Kern P, Holst FG et al. (1991) Activation of the host response in human plasmodium falciparum malaria. Relation of parasitemia to tumour necrosis factor/cachectin, thrombin-antithrombin III and protein C levels. Am J Med 91: 37–44

    Article  PubMed  CAS  Google Scholar 

  • Hojnik M, George J, Ziporen L, Shoenfeld Y (1996) Heart valve involvement (Libman Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93: 1579–1587

    PubMed  CAS  Google Scholar 

  • Howell MD, Geraci JM, Knowlton AA (2001) Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 54: 810–816

    Article  PubMed  CAS  Google Scholar 

  • Hüppe D et al. (1988) Blutgerinnung bei entzündlicher Darmerkrankung. Med Klin 83: 577–584

    PubMed  Google Scholar 

  • Kamphuisen PW, Eikenboom JC, Bertina RM (2001) Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21: 731–738

    PubMed  CAS  Google Scholar 

  • Kazory A, Ducloux D, Coaquette A, Manzoni P, Chalopin JM (2004) Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation 77: 597–607

    PubMed  Google Scholar 

  • Key NS, McGlennen RC (2002) Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med 126: 1367–1375

    PubMed  CAS  Google Scholar 

  • Kitchens CS (2002) The contact system. Arch Pathol Lab Med 126: 1382–1386

    PubMed  Google Scholar 

  • Kottke-Marchant (2002) Antithrombin deficiency. Issues in laboratory testing. Arch Pathol Lab Med 126: 1326–1336

    PubMed  CAS  Google Scholar 

  • Kottke-Marchant K, Comp P (2002) Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med 126: 1337–1348

    PubMed  CAS  Google Scholar 

  • Kottke-Marchant, Duncan A (2002) Antithrombin deficiency. Arch Pathol Lab Med 126: 1326–1336

    PubMed  CAS  Google Scholar 

  • Landolfi R, Marchioli R, Kutti J (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. NEJM 350: 114–124

    Article  PubMed  CAS  Google Scholar 

  • Lee AY (2002) Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treatment Rev 28: 137–140

    CAS  Google Scholar 

  • Lee AY (2003) Screening for occult cancer in patients with idiopathic venous thromboembolism: no. J Thromb Haemost 1: 2273–2274

    Article  PubMed  CAS  Google Scholar 

  • Lee AY, Levine MN (2003) Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation 107: I17–I21

    PubMed  Google Scholar 

  • Lee CH, Chen KS, Tsai FC, Chien YY, Lee N (2000) Concurrent thrombosis of cerebral and femoral arteries in a patient with nephrotic syndrome. Am J Nephrol 20: 483–486

    Article  PubMed  CAS  Google Scholar 

  • Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346: 752–763

    Article  PubMed  CAS  Google Scholar 

  • Lindhoff-Last E (2004) Maternal thrombophilia and obstetric complications. J Lab Med 28: 34–41

    Google Scholar 

  • Mann KG (2003) Thrombin formation. Chest 124: 4S–10S

    Article  PubMed  CAS  Google Scholar 

  • McGlennen RC, Key NS (2002) Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 126: 1319–1325

    PubMed  CAS  Google Scholar 

  • Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101: 576–583

    Article  PubMed  CAS  Google Scholar 

  • Miehsler W, Reinisch W, Valic E et al. (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53: 542–548

    Article  PubMed  CAS  Google Scholar 

  • Mulder LJMM, Spierings EIH (1987) Stroke due to intravascular coagulation in mycoplasma pneumoniae infection. Lancet II: 1152

    Google Scholar 

  • Nesheim M (2003) Thrombin and fibrinolysis. Chest 124: 33S–39S

    Article  PubMed  CAS  Google Scholar 

  • Nicolaides AN, Breddin HK, Fareed J et al. (2001) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20: 1–37

    PubMed  CAS  Google Scholar 

  • Orth SR, Ritz E (1998) Das nephrotische Syndrom. Internist 39: 1246–1252

    Article  PubMed  CAS  Google Scholar 

  • Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126:1304–1318

    PubMed  Google Scholar 

  • Rasmussen MS (2002) Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treatment Rev 28: 141–144

    CAS  Google Scholar 

  • Rezende SM, Simmonds RE, Lane DA (2004) Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 103: 1192–1201

    PubMed  CAS  Google Scholar 

  • Rinder HM, Schuster JE, Rinder CS, Wang C, Schweidler HJ, Smith BR (1998) Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 91: 1288–1294

    PubMed  CAS  Google Scholar 

  • Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60: 1340–1355

    PubMed  CAS  Google Scholar 

  • Schafer AI (2004) Thrombocytosis. NEJM 350: 1211–1219

    Article  PubMed  CAS  Google Scholar 

  • Schmitt J et al. (2004) Relationship between endogenous clotting factor activities and BMI, gender, age or oral contraceptive use. Haemostaseologie 24: A77

    Google Scholar 

  • Seriolo B, Accardo S, Garnero A, Fasciolo D, Cutolo M (1999) Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients. Rheumatology 38: 675–683

    PubMed  CAS  Google Scholar 

  • Sester U, Girndt M, Kaul H, Kuhlmann M, Kohler H (1998) Das nephrotische Syndrom. Urologe [A] 37: 537–545

    PubMed  CAS  Google Scholar 

  • Somers E, Magder LS, Petri M (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematodes. J Rheumatol 29: 2531–2536

    PubMed  CAS  Google Scholar 

  • Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. NEJM 343: 1846–50

    Article  PubMed  CAS  Google Scholar 

  • Sutherland DE, Weitz IC, Liebman HA (2003) Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis and treatment. Am J Haematol 72: 43–52

    Article  Google Scholar 

  • The Homocystein Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a metaanalysis. JAMA 288: 2015–2022

    Google Scholar 

  • Tirado I, Manuel Soria J, Mateo J et al. (2004) Association after linkage analysis indicates that homozygosity for the 46C→T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 91: 899–904

    PubMed  CAS  Google Scholar 

  • Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21: 3665–3675

    Article  PubMed  Google Scholar 

  • White RH (2003) The epidemiology of venous thromboembolism. Circulation 107: I4–I8

    Article  PubMed  Google Scholar 

  • Willeke A et al. (2002) Rationelle Thrombophilie-Diagnostik. Dt Ärztebl 99: A2111–2118

    Google Scholar 

  • Wilson QA et al. (1999) International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome. Arthritis & Rheumatism 42: 1309–1311

    CAS  Google Scholar 

Download references

Authors
  1. B. Linnemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Lindhoff-Last
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Experimentelle Onkologie und Therapieforschung, Ismaninger Str. 22, 81675, München

    Sylvia Haas (Professor, Dr. med.) (Professor, Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Linnemann, B., Lindhoff-Last, E. (2005). Thrombogenität verschiedener Krankheitsbilder. In: Haas, S. (eds) Prävention von Thrombosen und Embolien in der Inneren Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27118-X_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-27118-X_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22563-8

  • Online ISBN: 978-3-540-27118-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation